Iowa State University's College of Veterinary Medicine student Taylor Morrison presents a case of Diabetic Ketoacidosis in a feline patient as seen at Iowa Veterinary Specialties.
THIS SEMINAR GIVES THE BASIC OVERVIEW THAT HOW YOU CAN MANAGE THE PATIENT WHO COMES TO YOU A FLUID AND ELECTROLYTE IMBALANCE . AND BASIC MECHANISM OF HOMEOSTASTIS
Fluid Therapy is the administration of fluids to a patient as a treatment or preventative measure. It can be administered via an intravenous, intraperitoneal, intraosseous, subcutaneous and oral routes. 60% of total bodyweight is accounted for by the total body water.
Different fluids can be
cyrstalloids, colloids, hypertonic saline, hypotonic saline, ringer lactate.
THIS SEMINAR GIVES THE BASIC OVERVIEW THAT HOW YOU CAN MANAGE THE PATIENT WHO COMES TO YOU A FLUID AND ELECTROLYTE IMBALANCE . AND BASIC MECHANISM OF HOMEOSTASTIS
Fluid Therapy is the administration of fluids to a patient as a treatment or preventative measure. It can be administered via an intravenous, intraperitoneal, intraosseous, subcutaneous and oral routes. 60% of total bodyweight is accounted for by the total body water.
Different fluids can be
cyrstalloids, colloids, hypertonic saline, hypotonic saline, ringer lactate.
Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes. This condition is a complex disordered metabolic state characterized by hyperglycemia, ketoacidosis, and ketonuria.
FIRST TIME IN WORLD BOOK
https://www.crcpress.com/Pharmacology-Mind-Maps-for-Medical-Students-and-Allied-Health-Professionals/Bhandari/p/book/9781138351240
Iowa State University's College of Veterinary Medicine student Allison Masters presents a case of elevated liver enzymes as seen at Iowa Veterinary Specialties.
Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes. This condition is a complex disordered metabolic state characterized by hyperglycemia, ketoacidosis, and ketonuria.
FIRST TIME IN WORLD BOOK
https://www.crcpress.com/Pharmacology-Mind-Maps-for-Medical-Students-and-Allied-Health-Professionals/Bhandari/p/book/9781138351240
Iowa State University's College of Veterinary Medicine student Allison Masters presents a case of elevated liver enzymes as seen at Iowa Veterinary Specialties.
Iowa State University's College of Veterinary Medicine student Amy Gansemer presents a case of Pyometra in a canine patient as seen at Iowa Veterinary Specialties.
Iowa State University's College of Veterinary Medicine student Amanda Jondle presents a case of Veterinary Acupuncture as seen at Iowa Veterinary Specialties.
Iowa State University's College of Veterinary Medicine student Allison O'Connor presents a case of Tetanus in a canine patient seen at Iowa Veterinary Specialties.
Iowa State University's College of Veterinary Medicine student Haley Roecker presents a case of Chronic Renal Failure in a Feline patient at Iowa Veterinary Specialties.
Iowa State University's College of Veterinary Medicine student Allison Kirchgatter presents a case of Vestibular Disease in a geriatric canine patient as seen at Iowa Veterinary Specialties.
Diabetes mellitus, often referred to simply as DIABETES.
Diabetes is a condition in which the body:
Does not produce enough insulin, and/or
Does not properly respond to insulin
Insulin is a hormone produced in the pancreas. Insulin enables cells to absorb glucose in order to turn it into energy.
Type 1 diabetes:
Diagnosed in children and young adults
Previously known as Juvenile Diabetes
Type 2 diabetes:
Typically diagnosed in adulthood
Also found in overweight children
Complications of blood glucose alterations
Hypoglycemia
Hyperglycemia
Ketosis
Acidosis
DKA (Hyperglycemia + Ketosis + Acidosis)
Normal fasting blood glucose level 4-6 mmol/L
definition:
A state of absolute or relative insulin deficiency aggravated by ensuing hyperglycemia, dehydration, and acidosis-producing derangements in intermediary metabolism, including production of serum acetone.
Can occur in both Type I Diabetes and Type II Diabetes
– In type II diabetics with insulin deficiency/dependence
The presenting symptom for ~ 25% of Type I Diabetics.
160,000 Admissions to private hospitals/year
Cost = over 1 billion $ annually
65% = <19 years old
Main cause of death in children with diabetes (approximately 85%)
Cerebral edema in 69%
Hyperosmolar Hyperglycemic State (HHS):
An acute metabolic complication of diabetes mellitus characterized by impaired mental status and elevated plasma osmolality in a patient with hyperglycemia.
Occurs predominately in Type II Diabetics
– A few reports of cases in type I diabetics.
The presenting symptom for 30-40% of Type II diabetics.
Not commonly associated with ketonaemia and acidosis
The biochemical criteria for the diagnosis of DKA3,4
Hyperglycemia - blood glucose greater than 11.1 mmol/L
Ketosis - ketones present in blood and/or urine
Acidosis - pH less than 7.3 and/or
bicarbonate less than 15 mmol/L
DKA is generally categorized by the severity of the acidosis.
MILD – Venous pH less than 7.3 and/or
bicarbonate concentration less than 15 mmol/L
MODERATE – Venous pH less than 7.2 and/or
bicarbonate concentration less than 10 mmol/L
SEVERE – Venous pH less than 7.1 and/or
bicarbonate concentration less than 5 mmol/L
Risk factors:
Age <12 yrs
No first degree diabetic relative
Lower socioeconomic status
High dose glucocorticoids, atypical antipsychotics, diazoxide and some immunosuppresive drugs
Poor access to medical care
Uninsured
Usage of SGLT-2 inhibitor – euglycaemic DKA
SGLT2 inhibitors blunt insulin production in the face of stress hormones leading to increased ketotic metabolism
AETIOLOGY:
No carbohydrate intake
fasting
gastroenteritis
Atkins diet, neonates fed high-fat milk
Prolonged exercise, pregnancy
Lack of insulin activity
onset of diabetes (insufficient secretion)
interruption of insulin delivery in established pt
Increase in insulin resistance
infection, illness, surgery, stress
Alcohol, salicylate ingestion, inborn metabolic errors
Causes:
Stressful precipitating event that results in increased cate
DIABETIC KETOACIDOSIS (DKA):
A state of absolute or relative insulin deficiency aggravated by ensuing hyperglycemia, dehydration, and acidosis-producing derangements in intermediary metabolism, including production of serum acetone.
Can occur in both Type I Diabetes and Type II Diabetes
– In type II diabetics with insulin deficiency/dependence
The presenting symptom for ~ 25% of Type I Diabetics.
Hyperosmolar Hyperglycemic State (HHS): An acute metabolic complication of diabetes mellitus characterized by impaired mental status and elevated plasma osmolality in a patient with hyperglycemia.
Occurs predominately in Type II Diabetics
– A few reports of cases in type I diabetics.
The presenting symptom for 30-40% of Type II diabetics.
Not commonly associated with ketonaemia and acidosis
Classic Triad of DKA:
Hyperglycemia - blood glucose greater than 11.1 mmol/L
Ketosis - ketones present in blood and/or urine
Acidosis - pH less than 7.3 and/or
bicarbonate less than 15 mmol/L
DKA is generally categorized by the severity of the acidosis.
MILD – Venous pH less than 7.3 and/or
bicarbonate concentration less than 15 mmol/L
MODERATE – Venous pH less than 7.2 and/or
bicarbonate concentration less than 10 mmol/L
SEVERE – Venous pH less than 7.1 and/or
bicarbonate concentration less than 5 mmol/L
Risk factors for DKA at onset:
Age <12 yrs
No first degree diabetic relative
Lower socioeconomic status
High dose glucocorticoids, atypical antipsychotics, diazoxide and some immunosuppresive drugs
Poor access to medical care
Uninsured
Usage of SGLT-2 inhibitor – euglycaemic DKA
SGLT2 inhibitors blunt insulin production in the face of stress hormones leading to increased ketotic metabolism
Why do ketones develop?
No carbohydrate intake
fasting
gastroenteritis
Atkins diet, neonates fed high-fat milk
Prolonged exercise, pregnancy
Lack of insulin activity
onset of diabetes (insufficient secretion)
interruption of insulin delivery in established pt
Increase in insulin resistance
infection, illness, surgery, stress
Alcohol, salicylate ingestion, inborn metabolic errors
Causes of DKA/HHS: Stressful precipitating event that results in increased catecholamines, cortisol, glucagon.
Infection (pneumonia, UTI)
Alcohol, drugs
Stroke
Myocardial Infarction
Pancreatitis
Trauma
Medications (steroids, thiazide diuretics)
Non-compliance with insulin
DKA is a complex metabolic state of: hyperglycemia, ketosis, and acidosis
Symptoms include:
Deep, rapid breathing
Fruity breath odor
Very dry mouth
Nausea and vomiting
Lethargy/drowsiness
DKA is life-threatening and needs immediate treatment
Symptoms of DKA/HHS
Polyuria
Polydypsia
Blurred vision
Nausea/Vomiting
Abdominal Pain
Fatigue
Confusion
Obtundation
Physical Examination in DKA/HHS: Hypotension, tachycardia
Kussmaul breathing (deep, labored breaths)
Fruity odor to breath (due to acetone)
Dry mucus membranes
Confusion
Abdominal tenderness
Treatment of DKA:
Fluids and Electrolytes
Fluid replacement
–Restores perfu
Diabetes mellitus (DM) is a syndrome of chronic hyperglycaemia is due to one of two mechanisms:
Inadequate production of insulin , or
Inadequate sensitivity of cells to the action of insulin.
It affects more than 220 million people worldwide, and it is estimated that it will affect 440 million by the year 2030
"Diabetes" comes from the Greek word for "siphon", and implies that a lot of urine is made.
The second term,"mellitus" comes from the Latin word, "mel" which means "honey", and was used because the urine was sweet.
• The onset of type 1 diabetes may also be associated with sudden weight loss or nausea, vomiting, or abdominal pains, if DKA has developed.
This presentation is based on JBDS and BSPDE guidelines in adult and Paediatric DKA management. A comparison of adult vs paediatric management is included.
Similar to Diabetic Ketoacidosis or "DKA" in Cats (20)
University of Iowa's College of Veterinary Medicine student Heather Hagens presents a case of Feline Urethral Obstruction as seen at Iowa Veterinary Specialties.
This presentation covers the symptoms, diagnosis, and treatment of Canine Pancreatitis. Pancreatitis is the inflammation of the Pancreas. It is a common condition found in dogs and often requires hospitalization. Although the prognosis of a patient diagnosed with Pancreatitis is good, it may be fatal in some dogs.
A brief description of Feline Pneumonia; symptoms, risk factors, diagnosis, and treatment. Including a short case study on "Chester," a cat diagnosed with Feline Pneumonia.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
2. What is DKA?
• DKA is a metabolic disorder that occurs when the body
doesn’t produce enough insulin, or the tissues don’t
respond to the insulin.
– Insulin is responsible for transporting sugar into cells for use as energy.
Without insulin, the cells can’t perform normal functions and are essentially
“starved.”
• Increased production of hormones that have anti-insulin
effects such as glucagon, cortisol, and epinephrine, can
exacerbate the insulin deficiency or insulin resistance.
3. What is DKA?
• The liver responds by using fatty acids as an energy
source. The fats are converted into ketones (ketoacids).
This can lead to acidosis, electrolyte imbalances, and
signs of systemic illness.
• DKA is a life-threatening condition that requires
immediate medical attention!
4. Which Patients Develop DKA?
• Patients with diagnosed Diabetes Mellitus
• Patients with undiagnosed Diabetes Mellitus
• Patients with poorly managed or untreated Diabetes
Mellitus
5. Symptoms & Physical Exam Findings
• Increased drinking and urination
• Increased appetite
• Vomiting and/or diarrhea
• Weakness
• Anorexia and/or weight loss
• Dehydration
• “Fruity odor” to the breath (from the ketones)
• Enlarged liver
• Rapid breathing
6. Diagnosis of DKA
• Clinical Signs and Physical Exam
• Bloodwork
– Hyperglycemia (high glucose in the blood)
– Ketones in the blood
– Metabolic acidosis (low body pH)
– Electrolyte abnormalities
• Urinalysis
– Glycosuria (glucose in urine)
– Ketones in the urine
• The majority of patients with DKA also have a concurrent illness such as
pancreatitis or a urinary tract infection
7. Treatment of DKA
• Immediate hospitalization
• Fluid therapy, often with additional electrolytes added
• A few hours after starting fluid therapy, insulin is given to
help slowly lower the blood glucose concentration
• Broad-spectrum antibiotics to treat concurrent infection, or
anti-nausea medications may also be necessary
• After stabilization, patient will be started on subcutaneous
insulin that will be given long-term to control Diabetes
Mellitus
• Long-term change to high fiber diet
8. Prognosis for DKA
• Depends upon the progression of the disorder.
• Fair to guarded, with concurrent illness
leading to guarded prognosis
9. DKA Case Example: “Peanut”
• 7-year old neutered male domestic
shorthair cat
• Presented with a two-day history of
lethargy, anorexia, weight loss, and
increased drinking and urination.
• Peanut’s referring veterinarian had
seen Peanut earlier in the day, and lab
work showed glucose in the blood
and urine: both signs of potential
Diabetes Mellitus
10. “Peanut”
• Physical Exam Findings:
– Dehydrated
– Mild decrease in muscle mass
– Tense abdomen
– Poor haircoat
• Recommended hospitalization, abdominal radiographs,
bloodwork, and blood glucose monitoring.
11. “Peanut” Diagnostics
• Bloodwork: Hyperglycemia (high blood glucose),
acidemia (low blood pH), low potassium,
sodium, and chloride (electrolytes)
• Urine ketones: high
• Abdominal radiographs: no significant findings
12. “Peanut” Treatment
• Hospitalization
• Fluids with supplemental potassium
• Anti-nausea medications
• Insulin was started after Peanut became
re-hydrated.
• Blood glucose measurements were taken every
2 hours.
• High-Fiber Diet
13. “Peanut” Goes Home!
• Ketones in the urine resolved
• Electrolytes and blood glucose concentrations
stabilized
• Peanut began eating well
• Started on subcutaneous insulin that will continue to
be administered by Peanut’s owner at home
• Peanut’s owners were instructed to feed him twice a
day, and give insulin after he finishes each meal
14. Conclusion
• Patients that survive an episode of Diabetic
Ketoacidosis will need long-term care for
their Diabetes Mellitus
• DKA is a serious metabolic disorder. Please
bring your pet to the veterinarian
immediately if you notice any of the listed
symptoms